Session Type
Meeting
Search Results for infection
Oral Presentations
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Approximately 5-10% of the US population reports a Penicillin (PCN) allergy. Only 1 in 10 of these patients are found to have a positive reaction to PCN. This label comes at a grave cost, with higher incidences of multidrug-resistant nosocomial infections reported among these patients. With the lack of novel antibiotics and the alarming […]
Oral Presentations
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Inpatient antibiotic stewardship programs often use pre-prescription approval (PPA) or prospective audit and feedback (PAF) to reduce fluoroquinolone prescribing. Whether these stewardship strategies targeting inpatient fluoroquinolone use also influence prescribing at discharge is unknown. Therefore, we aimed to evaluate the effect of fluoroquinolone stewardship on discharge fluoroquinolone use in patients with pneumonia or a […]
Oral Presentations
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Approximately 5-10% of the US population reports a Penicillin (PCN) allergy. Only 1 in 10 of these patients are found to have a positive reaction to PCN. This label comes at a grave cost, with higher incidences of multidrug-resistant nosocomial infections reported among these patients. With the lack of novel antibiotics and the alarming […]
Oral Presentations
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Inpatient antibiotic stewardship programs often use pre-prescription approval (PPA) or prospective audit and feedback (PAF) to reduce fluoroquinolone prescribing. Whether these stewardship strategies targeting inpatient fluoroquinolone use also influence prescribing at discharge is unknown. Therefore, we aimed to evaluate the effect of fluoroquinolone stewardship on discharge fluoroquinolone use in patients with pneumonia or a […]
Abstract Number: 101
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: TOUR™ is a multicenter study designed to characterize the real-world population characteristics and clinical outcomes associated with telavancin (TLV) use through retrospective medical chart review. Telavancin is a lipoglycopeptide antibacterial active against gram-positive pathogens, including methicillin-sensitive and -resistant Staphylococcus aureus (MSSA and MRSA). In the US, TLV is approved for hospital-acquired (HABP) and ventilator-associated […]
Abstract Number: 106
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Hospitalized patients placed on contact, droplet, or respiratory isolation due to a carrier state or infection with resistant or highly communicable organisms report higher rates of anxiety and loneliness and have fewer physician encounters, room entries, vital sign records, physician and nursing notes in the chart. For these reasons, it has been hypothesized that […]
Abstract Number: 114
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Procalcitonin (PCT) is a precursor peptide to calcitonin produced by the thyroid parafollicular cells, and the intestinal and lung neuroendocrine cells. PCT is a proinflammatoy marker specific to bacterial infections, and was initially used clinically to guide antibiotic therapy in lower respiratory tract infections. PCT has seen its role expanded to aid with initiation, […]
Abstract Number: 125
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Patients with diabetic foot ulcers (DFUs) experience large burdens of morbidity, mortality, and hospital costs. Over a third of patients with diabetes will develop DFUs in their lifetime; and almost half of these patients subsequently develop diabetic foot infections (DFIs). Although it has been reported that obese patients with diabetes do not have higher […]
Abstract Number: 139
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Sepsis research is limited by heterogeneity and inaccuracy of patient identification. An ideal identification algorithm would broadly define a population with suspected infection to optimize discrimination and provide real-time identification of high-risk populations for potential interventions. We combined clinical and administrative to identify a population of adults hospitalized with suspected infection and examined characteristics […]
Abstract Number: 155
Hospital Medicine 2018; April 8-11; Orlando, Fla.